Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
August 15, 2018 - The FDA announced the approval of Lenvima (lenvatinib), for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC).
Return to publications